On-Demand
|
1 hour
Discussion Topics:
- Why the conventional wisdom about the COVID-19 curve and reopening decisions is flawed
- Key progress milestones that indicate narrowing scientific uncertainty
- Get the facts about testing, contact tracing, treatment, vaccines, and herd immunity
Organizations, governments, and individuals face challenging decisions with limited evidence-based scientific data to show the outcome of a choice during the COVID-19 pandemic. When considering re-opening, organizations must consider the implications of returning to the office, lifting travel restrictions, requiring masks, and restructuring space to allow social distancing. When even the most mundane daily activity involves risk, you must understand what factors to include in your mitigation strategy. This complimentary webinar uses the scientific cone of uncertainty to vet assumptions about testing, contact tracing, treatments, vaccines, and herd immunity that drive reopening decisions in healthcare. CIOs will get actionable recommendations to help their organizations get to a new normal.
Return to this web page to watch the webinar. Contact us at gartnerwebinars@gartner.com with questions about watching.
Show More
Show Less
Hosted by
Mandi Bishop
,
VP Analyst
Michael Shanler
,
Distinguished VP Analyst